Amarin drug will struggle against generics, says Summer Street

GlaxoSmithKline, Pfizer venture ViivV reports results from clinical study ViiV Healthcare announced initial results from the Phase IIIb/IV FLAMINGO study.

http://www.theflyonthewall.com/permalinks/entry.php/AMRN;GSKid1887125/AMRN;GSK-Amarin-drug-will-struggle-against-generics-says-Summer-Street